Loading
A. Palma, P. Pancheri - Vol. 6, Dicembre 2000, num.4
Testo Immagini Bibliografia Summary Riassunto Indice
Costrutti Teorici ed Obiettività clinico-sperimentale
dell'intervento terapeutico nelle Depressioni Minori, "Sintomatiche
Subcliniche" o "Subsindromiche"
Theoretical constructs and clinical-experimental objectivity of therapeutic
intervention in Minor,
"Sub-clinical Symptomatic" or "Sub-syndromal" Depressions
Depressive states and their borderlands: classification, diagnosis and treatment.
Compr Psychiatry 1960;4:135-55.
2 Kendell RE.
The continuum model of depressive illness
Proc R Soc Med 1969;72:335-9.
3 Sherbourne CD, Wells BK, Hays RD, Rogers W, Burnam MA, Judd LL.
Subthreshold depression and depressive disorder: clinical characteristics of general medical and mental health specialty outpatients.
Am J Psychiatry 1994;151:1777-84.
4 Judd LL, Rapaport MH, Paulus MP, Brown MA.
Subsyndromal symptomatic depression: a new mood disorder?
J Clin Psychiatry 1994;55:18-28.
5 Altshuler LL, Post RM, Leverich GS, Mikalauskas, Rosoff K, Ackerman L.
Antidepressant-induced mania and cycle acceleration: a controversy revisited.
Am J Psychiatry 1995;152:1130-8.
6 Ghaemi SN, Sachs GS, Chiou AM, Pandurangi AK, Goodwin FK
Is bipolar disorder still underdiagnosed? Are antidepressants overutilized?
J Affect Disord1999;52:135-44.
7 Cassano GB, Pancheri P.
Linee guida per il trattamento farmacologico dell’episodio depressivo. Consensus Conference, Firenze 24-25 Settembre 1993.
Riv Psichiatr 1994;29;5:3-23.
8 Pancheri P.
Linee guida sulla farmacoterapia dei disturbi dell’umore.
G Ital Psicopatol 1999;5(suppl.3):5-19.
9 Biondi M.
Terapie biologiche e psicoterapie.
In: Atti dei corsi Milano Medicina ’94 "La depressione oggi" Corriere Medico Aprile 1995;supp.14,18-19:74-7.
10 Roose SP, Glassman AH, Attia E, Woodring RN.
Comparative efficacy of selective serotonin reuptake inhibitors and tricyclics in the treatment of melancholia.
Am J Psichiatry 1994;90:1735-19.
11 Pancheri P.
La specificità terapeutica delle molecole antidepressive.
In: Pancheri P, Cassano GB, eds. Specificità e aspecificità terapeutica dei farmaci antidepressivi. Firenze: Scientific Press 1995.
12 Katz M, Klerman GL.
Introduction:overview of the clinical studies program.
Am J Psychiatry 1979;136:49-51.
13 Judd LL, Akiskal HS, Maser JD, Zeller PJ, Endicott J, Coryell, et al.
A prospective 12-year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders.
Arch Gen Psychiatry 1998;55:694-700.
14 Judd LL, Akiskal HS, Maser JD, Zeller PJ, Endicott J, Coryell et al.
Major depressive disorder: a prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse.
J Affect Disord 1998;50:97-108.
15 Angst J.
The prevalence of depression.
In: Montgomery SA, eds. Which antidepressant for which depression?
16 Maier W, Minges J, Franke P, Gansike M.
Personality patterns in subjects at risk for affective disorders.
Psychopatology 1995;28(suppl.1):59-72.
17 Maier W, Gansicke M, Weiffenbach O.
The relationship between major and subthreshold variants of unipolar depression.
J Affect Disord Agu 1997;45:1-2:41-51.
18 Callieri B.
La sofferenza note di psicopatologia antropologica.
In: Callieri B. Percorsi di uno psichiatra. Roma: Edizioni Universitarie Romane 1993.
19 Jaspers K.
Allgemeine Psychopatologie.
Berlin: Sprinter Verlag, 1959. (Trad. it. Priori R. ed. Psicopatologia generale. Roma: Il Pensiero Scientifico Editore, 1964).
20 Biondi M.
La mente selvaggia. Un saggio sulla normalità nei comportamenti umani.
Roma: Il Pensiero scientifico 1996.
21 Reda GC.
Introduzione.
In: Reda GC, ed. Trattato di Psichiatria. USES, Firenze, 1981.
22 Baldwin RC.
Prognosis of depression.
Curr Op Psichiatry 2000;13:81-5.
23 Pancheri P.
Stress e depressione: dalla reazione adattativi normale allo scompenso patologico.
Riv Psichiatr 1982;17:3-21.
24 Bech P.
Acute therapy of depression.
J Clin Psychiatry 1993;54;(suppl.):18-28.
25 Andrews W, Parker G, Barret E.
The antiderpessants: exploring their other possibile properties.
J Affect Disord 1998;49:141-4.
26 Szegedi A, Wetzel H, Angersbach D, Philipp M, Benkert O.
Response to treatment in minor and major depression: results of a double-blind comparative study with paroxetine and maprotiline.
J Affect Disord 1997;45:167-78.
27 Gumbiner J, Flowers J.
Sex differences on the MMPI-1 and MMPI-2.
Psychol Rep 1998;81:479-82.
28 Hylan TR, Meneades L, Crown WH, Sacristan JA, Gilaberte I, Montejo AL.
SSRI antidepressant use patterns and their relation to clical global impression score: a naturalistic study.
J Affect Disord 1999;52:111-9.
29 Maj M, Veltro F, Dirozzi R, Lo Brace S, Magliano L.
Pattern of recurrence of illness after recovery from an episode of major depression: a prospective study.
Ame J Psychiatry 1992;149:795-800.
30 Räsänen P, Hakko H, Jokelainen Tiihonen.
Outcome of different types of long-term antidepressant treatment: a 3-year follow-up study of 14 182 patients.
J Affect Disord 1999;5:67-71.
31 Jaquenoud E, Kat M.
The safety of fluvoxamine in very elderly patients with depression and somatic symptoms.
Prim Care Psychiatry 1997;3:178-81.
32 Romiti R.
Farmaci psicoattivi e sistema cardiocircolatorio.
G Ital Psicopatologia 1998;1:99-121.
33 Schweizer E, Weise C, Clary C, Fox I, Richels K.
Placebo-controlled trial of venlafaxine for treatment of major depression.
J Clin Psychopharmacol 1991;11:233-6.
34 Schweizer E, Feighner J, Mandons LA Richels K.
Comparison of venlafaxine and imipramine in the acute treatment of major depression in outpatients.
J Clin Psichiatry 1994;55:104-8.
35 Samuelian JC, Tatossian A, Hackett D.
A randomized, double-blind, parallel group comparison of venlafaxine and clomipramine in outpatients with major depression.
J Psychopharmacol 1998;12:273-8.
36 Dierick M, Martin A, Ravizza L, Reliani R.
A double-blind comparison of venlafaxine and fluoxetine for treatment of major derpession in outpatients.
Prog Neuropsychopharmacol 1995 (in press).
37 Hackett D.
Tolerability of once day formulation of venlafaxine.
Biol Psychiatry 1997;42(suppl.):244S.
38 Romiti R, Pancheri P.
Le depressioni moderate a componente ansiosa: un target terapeutico specifico per la Venlafaxina a rilascio prolungato (RP).
Giorn Ital Psicopatol 1999;5:201-12.
39 Brugnoli R, Palma A.
Effetti collaterali ed indesiderati in corso di trattamento antidepressivo.
NÓOV 1999;vol.5,2:85-105.
40 Kasper S, Zivkov M, Roes KCB, et al.
Pharmacological treatment of severely depressed patients: a meta-analysis comparing efficacy of mirtazapine and amitripytline.
Eur Neuropsychopharmacol 1997;7:115-24.
41 Decina P, Scapicchio PL, Trabucchi M.
Gli antidepressivi atipici.
In: Decina P, Scapicchio PL, Trabucchi M, eds. Farmacoterapia in Psichiatria. Napoli: Idelson 1994:93-7.
42 Jenkis SC, Gibbs SC, Szymanski SR.
Manuale tascabile per gli psichiatri.Criteri clinici e terapeutici.
Milano Masson 1992.Traduzione a cura di Marazziti D. 1997;7:115-24.
43 Bellantuomo C, Balestrieri M, Nicolau S.
Gli psicofarmaci nella terapia delle sindromi depressive.
In: Tansella M, Bellantuomo C, eds. Gli psicofarmaci nella pratica terapeutica.Terza edizione.Roma: Il Pensiero Scientifico 1994:387-9.
44 Bottiglieri T.
Ademetionine (S-adenosylmethionine) neuropharmacology: implications for drugs therapies in psychiatric and neurogical disorders.
Exp Opin Invest Drug 1997;6:417-26.
45 Zanotti S, Mori S, Radaelli R, Perez J, Racagni G, Popoli M.
Modification in brain cAMP, and calcium/calmodulin-dependent protein kinases induced by treatment with S-adenosylmethionine.
Neuropharmacology 1998;37:1081-9.
46 Pancheri P, Racagni R, Delle Chiaie R, Popoli M.
Nuove acquisizioni sperimentali e cliniche sulla efficacia e tollerabilità della Ademetionina come antidepressivo.
G Ital Psicopatol 1997;2:138-60.
47 Mantero M, Pastorini P, Carolei A, Agnoli A.
Studio controllato in doppio cieco (SAMe-imipramina) nelle sindromi depressive.
Minerva Med 1975;66:4098-101.
48 Scarsella R, Appiatti A.
Confronto clinico in doppio cieco della SAMe e vs clorimipramina nelle sindromi depressive.
Riv Sper Freniatr 1978;102:344-58.
49 Delle Chiaie R, Pancheri P.
Analisi combinata di due studi controllati, multicentrici in doppio cieco per la valutazione di efficacia e tollerabilità di SAMe vs. placebo (MC1) e di SAMe vs. clomipramina (MC2) nel trattamento della depressione Maggiore.
Giorn Ital Psicopatol 1999;5:45-53.
50 Danish University Antidepressant Group (DUAG).
Citalopram: clinical effect profile in comparison with clomipramine. A controlled multicenter study.
Psychopharmacology 1986;90:131-8.
51 Danish University Antidepressant Group (DUAG).
Paroxetine: a selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicentric study.
J Affect Disord 1990;18:289-299.
52 Danish University Antidepressant Group (DUAG).
Moclobemide: a reversible MAO-A-inhibitor showing weaker antidepressant effect than clomipramine in a controlled multicenter study.
J Affect Disord 1993;28:105-16.
53 Delle Chiaie R, Pancheri P, Scapicchio PL.
Results of two multicentre controlled efficacy and safety trials of oral (MC3) and intramuscolar (MC4) s-adenosyl-methionine (SAMe) vs. oral imipramine in the treatment of depression.
Submitted at: 154-th Annual Meeeting of the American Psychiatric Association (APA), New Orleans, LA, may 2001.
54 Bottiglieri T, Chary TKN, Carney MWP, et al.
Cerebrospinal fluid S-adenosylmethionine in depression and dementia: the effect of parental and oral treatment.
J Neurol Neurosurg Psychiatr 1990;53:1096-8.
55 Reynolds EH, Carney MWP, Toone BK, et al.
Transmetilation and neuropsychiatry.
In: Mato J, ed. Biochemical, Pharmacological and Clinical aspects of transmetilation. Cell Biol Rev 2:93-102.
56 Montanari D, Di Palma C, Giorgetti G, Violante F, Voltolina M.
Effects of S-adenosy-L-methionine on cognitive and vigilance functions in the elderly.
Curr Theor Res 1994;312:874-9.
57 Gloaguen V, Cottraux J, Cucherat M, Blackburn I-M.
A meta-analysis of the effects of cognitive therapy in depressed patients.
J Affect Disord 1998;49:59-72.
58 Dobson KS.
A meta-analysis of the efficacy of cognitive therapy for depression.
J Consult Clin Psychol 1989;57:414-9.
59 Svarteberg M, Stiles TC.
Comparative effects of short-term psychodinamic psychoterapy: a meta-analysis.
J Consult Clin Psychol 1991;59:704-14.
60 Thase ME, Friedman E.
Is psychotherapy an effective treatment for melancholia and other severe depressive state?
J Affect Disord 1999;54:1-19.